Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Howard Jacob Leaving HudsonAlpha For AbbVie

    Jan 16, 2018, 09:10 AM by Michael Croft

    Bio-IT World | Less than three years after leaving the Medical College of Wisconsin for the HudsonAlpha Institute in Huntsville, Alabama, Howard Jacob is starting today as the Vice President of the Genomic Research Center at AbbVie.

    Full story
  • Aalto Bio Reagents Announces Availability of Mouse Monoclonal Antibody to Helicobacter Pylori Flagellin for Diagnostic Testing

    Jan 16, 2018, 07:37 AM by Michael Croft
    DUBLIN, IRELAND - Jan 16, 2018 - Dublin, Ireland – January 16th, 2018 –Aalto Bio Reagents is pleased to announce availability of its new mouse monoclonal antibody to Helicobacter pylori flagellin for diagnostic test manufacturers, vaccine developers and researchers globally
    Full story
  • Bioinformatics firm Mind the Byte acquires Intelligent Pharma

    Jan 16, 2018, 06:34 AM by Michael Croft
    BARCELONA, SPAIN - Jan 16, 2018 - Bioinformatics firm Mind the Byte, a pioneer in the development of technologies based on artificial intelligence, cloud and big data for computational drug design, has acquired 100% of Intelligent Pharma, one of the leaders in Spain in chemoinformatics services for the pharmaceutical and biotechnology industry
    Full story
  • DNA Sequencing Holds Some Promise For Treating Tumors

    Jan 15, 2018, 16:08 PM by Michael Croft
    NPR | Sequencing the DNA of cancer tumors to help pinpoint treatment is an emerging element of precision medicine. While patients and doctors alike want these tests, they often don't benefit patients.
    Full story
  • 23andMe CEO Goes Beyond “Wall Of A White Coat”

    Jan 15, 2018, 12:55 PM by Michael Croft

    Bio-IT World | Speaking at the 36th annual JP Morgan Healthcare Conference, 23andMe’s CEO and co-founder Anne Wojcicki reflected on the scope of the 23andMe’s dataset, especially as it pertains to healthcare and drug discovery.

    Full story
  • Meditraq launches to simplify serialisation data challenge

    Jan 15, 2018, 11:44 AM by Michael Croft
    ETTEN-LEUR, NETHERLANDS - Jan 15, 2018 - A new serialisation implementation partner has formed to assist the increasing number of companies needing to meet the data requirements of looming global regulation changes
    Full story
  • JP Morgan 2018 News Roundup

    Jan 12, 2018, 13:35 PM by Michael Croft

    Bio-IT World | The 36th annual JP Morgan Healthcare Conference was held this week in San Francisco, bringing together more than 400 companies to showcase their growth and innovation. Here are some of the highlights and announcements we’ve collected from the conference.

    Full story
  • Nonprofit Price For New Childhood Blindness Therapy 4X Too High

    Jan 12, 2018, 12:22 PM by Michael Croft
    STAT | Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.
    Full story
  • BioIVT Launches Scientific Advisory Board, Expands Drug Development Expertise

    Jan 11, 2018, 10:23 AM by Michael Croft
    WESTBURY, NY - Jan 11, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced the launch of its BioIVT Scientific Advisory Board (SAB)
    Full story
  • MDI Biological Laboratory Discovery Could Lead to New Therapies for Diabetics

    Jan 10, 2018, 16:42 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Jan 10, 2018 - New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes
    Full story
  • TARGET PharmaSolutions to advance NASH Research through New Collaboration

    Jan 10, 2018, 10:46 AM by Michael Croft
    CHAPEL HILL, NC - Jan 10, 2018 - TARGET PharmaSolutions, Inc., a real-world data solutions company, is pleased to announce that Novartis has entered into a long-term strategic alliance for TARGET-NASH
    Full story
  • Genedata Screener Raises the Bar on Automation in 2018

    Jan 9, 2018, 10:09 AM by Michael Croft
    BASEL, SWITZERLAND - Jan 9, 2018 - Genedata, a leading provider of advanced software solutions for R&D, today announced that Genedata Screener® has been enhanced towards full automation of the planning, execution, and data analysis of screening experiments
    Full story
  • BC Platforms to Provide Big Data Driven Research Solutions to Amgen in Cardiovascular Diseases and Oncology

    Jan 9, 2018, 02:18 AM by Michael Croft
    BASEL, SWITZERLAND - Jan 9, 2018 - BC Platforms, a world leader in genomic data management and analysis solutions, today announces that Amgen Finland will be using its technology solutions and research platform, including Full story
  • Creative Diagnostics Launches Epigenetics Antibodies for Bio-research Communities

    Jan 8, 2018, 22:34 PM by Michael Croft
    SHIRLEY, NY - Jan 9, 2018 - As a leading supplier of high quality antibodies validated for use in multiplexed assays, Creative Diagnostics recently launches epigenetics antibodies to global academic, pharmaceutical and biotech communities for specific and reproducible epigenetic target detection
    Full story
  • Illumina Announces iSeq 100, Thermo Fisher Partnership

    Jan 8, 2018, 21:30 PM by Michael Croft
    Bio-IT World  In the company’s JP Morgan presentation today, Illumina president and CEO Francis deSouza summarized the past year for the sequencing giant, highlighted expected areas of growth—consumer genomics, non-invasive prenatal testing—and announced the launch of the iSeq 100 Sequencing System and library prep partnership with Thermo Fisher.
    Full story
  • Genomics England Uses DRAGEN Pipeline To Re-Analyze 5000 Whole Genomes

    Jan 8, 2018, 09:35 AM by Michael Croft
    Bio-IT World Brief  Genomics England is currently using Edico Genome’s DRAGEN analysis pipeline to re-process 5,000 whole human genomes from individuals with rare diseases. Genomics England and Edico announced the partnership today at the annual J.P. Morgan Healthcare Conference.
    Full story
  • SYGNIS AG launches TruePrime™ apoptotic cell free DNA amplification kit for the liquid biopsy market

    Jan 8, 2018, 07:48 AM by Michael Croft
    , HEIDELBERG, GERMANY AND CAMBRIDGE, UK - Dec 6, 2017 - SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C
    Full story
  • At Least Three Billion Computer Chips Have the Spectre Security Hole

    Jan 5, 2018, 15:42 PM by Michael Croft
    MIT Technology Review | Tech companies are still working overtime on patching two critical vulnerabilities in computer chips that were revealed this week.
    Full story
  • Foxconn Builds Taiwan’s Largest Supercomputer

    Jan 5, 2018, 10:40 AM by Michael Croft
    TOP500 | A six-petaflop system has been installed at Taiwan's Kaohsiung Software Technology Park, making it the most powerful supercomputer in the country.
    Full story
  • Rho Announces Kristen Harrington’s Appointment to VP of Southeast SAS® Users Group (SESUG)

    Jan 4, 2018, 16:24 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Jan 4, 2018 - For Immediate Release Rho Announces Kristen Harrington's Appointment to VPof Southeast SAS® Users Group (SESUG)    Chapel Hill, NC  ̶  January 4, 2018  ̶  Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced that Principal Programmer/Analyst and Statistical Programming Operational Service Lead Kristen Harrington has been appointed to vice president of SESUG, a Regional Users Group (RUG) for users of SAS® Software
    Full story
  • «
  • 301 (current)
  • 302
  • 303
  • 304
  • 305
  • 306
  • 307
  • 308
  • 309
  • 310
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy